Grand Shuyang

Grand Shuyang is a specialized biopharmaceutical company based in China that focuses on the development and production of plasma-derived medicinal products (PDMPs). As a key subsidiary of China Grand Pharmaceutical and Healthcare Holdings, the company operates a comprehensive blood products platform including plasma collection, fractionation, and purification. Its commercial portfolio features essential therapies such as Human Albumin, Intravenous Immunoglobulin (IVIG), and specialized immunoglobulins for Hepatitis B and Tetanus. Grand Shuyang maintains high-standard GMP manufacturing facilities in Jiangsu Province and is actively expanding its pipeline into high-demand areas like coagulation factors to support the growing Chinese healthcare infrastructure. The company is one of a limited number of entities in China licensed to operate in the highly regulated blood products sector.